Trials / Completed
CompletedNCT00436475
Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the randomized trial is to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for type 2 diabetes.
Detailed description
There is animal and human observational evidence to suggest that vitamin D and calcium are important in modifying t2DM risk but there are critical gaps in our knowledge about the clinical magnitude of the association with t2DM and potential mechanisms in humans. We are conducting a randomized trial to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for t2DM. We anticipate that the research proposed in this application is significant because it will provide the basis for defining feasible nutritional interventions that promotes prevention of t2DM. Based on the results of the proposed studies and future work in this area, vitamin D and calcium supplementation can assume an important role in the treatment of t2DM and in the prevention of the disease in the 41 million Americans who are at risk of developing t2DM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D3 2,000 IU orally once daily | Vitamin D3 2,000 IU orally once daily |
| DRUG | Calcium Carbonate 400 mg orally twice daily | Calcium Carbonate 400 mg orally twice daily |
| DRUG | Vitamin D3-Placebo | Vitamin D3-Placebo |
| DRUG | Calcium-Placebo | Calcium-Placebo |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2007-02-19
- Last updated
- 2019-07-30
- Results posted
- 2019-07-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00436475. Inclusion in this directory is not an endorsement.